Octaplasmalg (A) (Human Plasma Protein)

Human Plasma Protein, the active ingredient in Octaplasmalg (A), is a plasma‑derived protein therapy presented as a sterile liquid for intravenous use. It is employed to support hemostasis in patients with complex coagulation needs, particularly in surgical and trauma settings. GNH USA supplies Octaplasmalg (A) as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.

GNH USA supplies Octaplasmalg (A) as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.

Octaplasmalg (A) is used in clinical situations that require replacement of multiple coagulation factors to achieve hemostasis.

- Major surgery: Provides broad-spectrum coagulation factor support to reduce intra‑operative bleeding. - Trauma care: Helps restore clotting ability in patients with massive hemorrhage. - Liver transplantation: Supplies necessary plasma proteins to manage coagulopathy during the procedure. - Disseminated intravascular coagulation (DIC): Assists  with  reconstitution  of  the  coagulation cascade. - Congenital plasma‑deficient   un  ​  ​  conditions  :  supplement   ​   ​  pl  ​  pl   ​  pl   ​  pl   ​ ​  .